These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 27732970)

  • 21. New and emerging therapies for advanced or metastatic soft tissue sarcoma.
    Gettys SC; Anderson JE; Davis JE
    J Oncol Pharm Pract; 2014 Aug; 20(4):288-97. PubMed ID: 24022407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temozolomide post pazopanib treatment failure in patients with advanced sarcoma: A case series.
    Bupathi M; Hays JL; Chen JL
    PLoS One; 2017; 12(11):e0188116. PubMed ID: 29141017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel targeted therapies in the treatment of soft-tissue sarcomas.
    Chao J; Chow WA; Somlo G
    Expert Rev Anticancer Ther; 2010 Aug; 10(8):1303-11. PubMed ID: 20735315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Next-Generation Sequencing as a Diagnostic Tool for the Evaluation of Bone and Soft-Tissue Tumors.
    Szurian K; Kashofer K; Liegl-Atzwanger B
    Pathobiology; 2017; 84(6):323-338. PubMed ID: 28817827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newer medical therapies for metastatic soft tissue sarcoma.
    Tiwari A; Gupta VG; Bakhshi S
    Expert Rev Anticancer Ther; 2017 Mar; 17(3):257-270. PubMed ID: 28103739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensity of recent years in the investigation of soft tissue sarcoma.
    Blay JY
    Future Oncol; 2017 Jun; 13(13s):3-9. PubMed ID: 28460535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in sarcoma molecular diagnostics.
    Wang XQ; Goytain A; Dickson BC; Nielsen TO
    Genes Chromosomes Cancer; 2022 Jun; 61(6):332-345. PubMed ID: 35064596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HDAC Inhibition for the Treatment of Epithelioid Sarcoma: Novel Cross Talk Between Epigenetic Components.
    Lopez G; Song Y; Lam R; Ruder D; Creighton CJ; Bid HK; Bill KL; Bolshakov S; Zhang X; Lev D; Pollock RE
    Mol Cancer Res; 2016 Jan; 14(1):35-43. PubMed ID: 26396249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current management options for liposarcoma and challenges for the future.
    Kollár A; Benson C
    Expert Rev Anticancer Ther; 2014 Mar; 14(3):297-306. PubMed ID: 24397249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular Target Therapy for Soft Tissue Sarcoma].
    Takahashi S
    Gan To Kagaku Ryoho; 2017 Jun; 44(6):457-462. PubMed ID: 28698433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Current Landscape of Early Drug Development for Patients With Sarcoma.
    Wilky BA; Jones RL; Keedy VL
    Am Soc Clin Oncol Educ Book; 2017; 37():807-810. PubMed ID: 28561654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomic research in sarcomas - current status and future opportunities.
    Burns J; Wilding CP; L Jones R; H Huang P
    Semin Cancer Biol; 2020 Apr; 61():56-70. PubMed ID: 31722230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies and methodologies for identifying molecular targets in sarcomas and other tumors.
    Ravi V; Wong MK
    Curr Treat Options Oncol; 2005 Nov; 6(6):487-97. PubMed ID: 16242053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. European Journal of Cancer's Biennial report on soft tissue and visceral sarcomas or the rapid evolution of treatment concepts in sarcomas.
    Blay JY; Brahmi M; Ray-Coquard I
    Eur J Cancer; 2017 Jan; 70():83-86. PubMed ID: 27889671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Medication Therapy for Soft Tissue Sarcoma (Current Status and Future Perspective)].
    Ando M
    Gan To Kagaku Ryoho; 2016 Jan; 43(1):27-32. PubMed ID: 26809524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted therapy and promising novel agents for the treatment of advanced soft tissue sarcomas.
    Mohindra N; Agulnik M
    Expert Opin Investig Drugs; 2015; 24(11):1409-18. PubMed ID: 26289790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in the Molecular Analysis of Soft Tissue Tumors and Clinical Implications.
    Marino-Enriquez A
    Surg Pathol Clin; 2015 Sep; 8(3):525-37. PubMed ID: 26297069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Changes Associated With Tumor Initiation and Progression of Soft Tissue Sarcomas: Targeting the Genome and Epigenome.
    Halcrow PW; Dancer M; Panteah M; Walden C; Ohm JE
    Prog Mol Biol Transl Sci; 2016; 144():323-380. PubMed ID: 27865462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic Therapy for Advanced Soft Tissue Sarcoma.
    Sheng JY; Movva S
    Surg Clin North Am; 2016 Oct; 96(5):1141-56. PubMed ID: 27542647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The promise of signal transduction in genetically driven sarcomas of the nerve.
    Kim A; Pratilas CA
    Exp Neurol; 2018 Jan; 299(Pt B):317-325. PubMed ID: 28859862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.